Clinical Trials Browser

Phase 1/2 × ribociclib × Tumor-Agnostic × Clear all

NCT04802759 2026-05-11

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Phase 1/2 Recruiting

Neoplasm Metastasis

NCT02813135 2026-01-16

ESMART

Phase 1/2 Recruiting

Neoplasms